U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C13H17N3.ClH.H2O
Molecular Weight 269.77
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TRAMAZOLINE HYDROCHLORIDE MONOHYDRATE

SMILES

O.Cl.C1CN=C(NC2=CC=CC3=C2CCCC3)N1

InChI

InChIKey=FDPYEAXJRLQOGE-UHFFFAOYSA-N
InChI=1S/C13H17N3.ClH.H2O/c1-2-6-11-10(4-1)5-3-7-12(11)16-13-14-8-9-15-13;;/h3,5,7H,1-2,4,6,8-9H2,(H2,14,15,16);1H;1H2

HIDE SMILES / InChI

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula H2O
Molecular Weight 18.0153
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C13H17N3
Molecular Weight 215.2942
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Tramazoline is a sympathomimetic drug that is used in the form of tramazoline hydrochloride in nasal decongestant preparations. Tramazoline is an α-adrenergic receptor agonist that inhibits secretion of nasal mucus.

Originator

Approval Year

Targets

Primary TargetPharmacologyConditionPotency
16.0 nM [IC50]

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Spray-Tish

Doses

PubMed

Sample Use Guides

In Vivo Use Guide
The recommended dose for adults and children six years of age and over is 1 to 2 sprays into each nostril up to four times daily as required.
Route of Administration: Nasal
In Vitro Use Guide
Binding affinity of Tramazoline against Alpha-2 adrenergic receptor measured as the ability to inhibit the specific [3H]clonidine binding (0.4 nM) to rat isolated brain membranes by 50% was 16 nM.
Substance Class Chemical
Record UNII
9DF5N42U1U
Record Status Validated (UNII)
Record Version